Email
Password
Remember meForgot password?
Log in with Facebook Log in with Twitter
Connect your Digital Journal account with Facebook or Twitter to use this feature.
Blog In Health

FDA approves obesity drug

blog:17270:2::0
By Tim Sandle
Posted Jul 3, 2012 in Health
The U.S. Food and Drug Administration has approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
For more details, see the FDA.

blog:17270:2::0
More about Obesity, Fda, Drug

Corporate

Help & Support

News Links

copyright © 2014 digitaljournal.com   |   powered by dell servers